Evidence map›Paper›PMID 41606475›Full record

ArticleBMC gastroenterology2026

Predicting clinical outcomes in Helicobacter pylori-positive patients using supervised learning through the integration of demographic and genomic features.

Venkatesh Narasimhan, Sreya Pulakkat Warrier, Jobin Jacob John, Monisha Priya T, Niriksha Varadaraj, Greeshma Grace Thomas, Balaji Veeraraghavan

Abstract read
In one paragraph

Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Association of Resistance-AssociatedAntibiotics (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Venkatesh Narasimhan *Department of Clinical Microbiology, Christian Medical College and Hospital, Vellore, India.ORCID http://orcid.org/0009-0002-6589-6197
Sreya Pulakkat Warrier *Department of Clinical Microbiology, Christian Medical College and Hospital, Vellore, India.ORCID http://orcid.org/0009-0008-9048-2862
Jobin Jacob JohnDepartment of Clinical Microbiology, Christian Medical College and Hospital, Vellore, India.ORCID http://orcid.org/0009-0009-7745-192X
Monisha Priya TDepartment of Clinical Microbiology, Christian Medical College and Hospital, Vellore, India.
Niriksha VaradarajDepartment of Clinical Microbiology, Christian Medical College and Hospital, Vellore, India.
Greeshma Grace ThomasDepartment of General Medicine, Christian Medical College and Hospital, Vellore, India.
Balaji VeeraraghavanDepartment of Clinical Microbiology, Christian Medical College and Hospital, Vellore, India. vbalaji@cmcvellore.ac.in.ORCID http://orcid.org/0000-0002-8662-4257

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHelicobacter pylori (H. pylori) infection is widespread globally and is linked to outcomes ranging from chronic gastritis to gastric cancer. However, only a minority of infected individuals progress to malignancy, influenced by a mix of bacterial, host, and environmental factors. Current predictive approaches are limited due to relying mainly on clinical and lifestyle data. Genomic approaches have been sparsely used, and thus their incorporation into machine learning models could ensure early and personalized detection. This study aimed to evaluate the impact of integrating host metadata with genomic features from H. pylori to predict gastric cancer outcomes and identify associated variables.

methodsOne thousand three hundred sixty-three publicly available H. pylori genomes with associated host information between 1991 and 2024 were collected from NCBI and EnteroBase. Demographic features, virulence genes, sequence-derived and variant-based features were extracted. Machine learning models were then developed to classify infection outcomes into gastric cancer and non-gastric cancer and trained using internal cross-validation folds within the training set comprising 80% of the dataset. Logistic regression, an interpretable baseline model, was compared against higher-performance ensemble models (XGBoost, Random Forest). Final model performance was assessed on the held-out test set using recall, precision, AUROC, and AUPRC curves.

resultsThe logistic regression model achieved a recall of 0.737 (95% CI: 0.637–0.830) for gastric cancer and an AUROC of 0.830 (95% CI: 0.779–0.880). Both XGBoost and Random Forest models outperformed the baseline model with AUROC values ranging from 0.950 to 0.954 (95% CI: 0.904–0.976). Black-box model recall for gastric cancer detection improved compared to the baseline by 8.14% for XGBoost (0.797, 95% CI: 0.711–0.877), and 11.3% for Random Forest (0.820, 95% CI: 0.734–0.896). Across models, patient age consistently emerged as the strongest predictor of gastric cancer, with several sequence-derived genomic features beyond pre-established virulence genes contributing to the infection outcome differences.

conclusionThis study demonstrates that combining pathogen genomics with host demographics uncovers novel risk factors and ensures early detection with high predictive power. The use of explainability methods like SHAP allows for greater interpretability by clinical professionals and improves informed decision-making processes. While internal validation showed strong performance, external validation on independent data and translation into clinical practice is necessary using broader, diverse datasets, along with the inclusion of additional host and lifestyle variables.

Indexed as

Helicobacter InfectionsHelicobacter pyloriStomach NeoplasmsSupervised Machine LearningBoosting Machine Learning AlgorithmsClassification AlgorithmsFemaleGenome, BacterialGenomicsHumansLogistic ModelsPrediction AlgorithmsPredictive Learning ModelsRandom ForestEnsemble learningGastric cancerGenomic sequence-based feature extractionHelicobacter pyloriMachine learningSHAP interpretabilitySupervised machine learning

Identifiers

PMID41606475
PMCPMC12922380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.